Global /United States /Healthcare /Medical Distribution /MYO
chevron_leftBack
Myomo, Inc. logo

Myomo, Inc.

MYO
NYSEAMERICAN: MYO Delayed
0.7920USD -3.5%
As of 13 June 2026, Myomo, Inc. has a market cap of $30.5M USD, ranking #34138 globally and #4785 in the United States. It ranks #3081 in the Healthcare sector, and #135 in the Medical Distribution industry.
Global Rank
34138
Country Rank
4785
Sector Rank
3081
Industry Rank
135
Key Stats
Market Cap
$30.5MUSD
Enterprise Value
$31.49MUSD
Revenue (TTM)
$40.93MUSD
EBITDA (TTM)
-$13.54MUSD
Net Income (TTM)
-$15.57MUSD
EBITDA Margin
-33%
Profit Margin
-38%
PS Ratio
0.7
PB Ratio
2.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Distribution
CEO
Paul Gudonis open_in_new
Employees
195
Founded
2004
IPO
12 Jun 2017
Website
myomo.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-3.5% -0.7% 15% -7.2% -21% -83%

News

Loading...

MYO Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NYSE American
MIC: XASE
PRIMARY
MYO
Myomo Inc
ISIN: US62857J2015
Shares Out.:
38.639M1 Shares Float: 35.796M2
TV:
SA:
YF:
MYO
GF:
NQ:
MYO
BA:
MYO
MS:
0.7920 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Myomo, Inc.

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran’s administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.

Similar Companies

Industry: Medical Distribution (United States)
Name
Market Cap diff.
PE
MCK
$100.76B
330K%
24.0
COR
$60.58B
199K%
37.4
$47.73B
156K%
29.6
HSIC
$8.47B
28K%
22.6
OLPX
$1.37B
4K%
-
$266.77M
775%
-
Industry: Medical Distribution (Global)
Name
Market Cap diff.
PE
$7.48B
58.61B HKD
24K%
7.2
GALE
$5.27B
4.2B CHF
17K%
23.0
DKSH
$4.8B
3.83B CHF
16K%
18.9
$3.82B
25.88B CNY
12K%
13.3
4164
$3.65B
13.7B SAR
12K%
16.5
$3.61B
577.66B JPY
12K%
14.1
chevron_leftBack